Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suvorexant: a promising, novel treatment for insomnia
James M. Parish, Joyce Lee‐Iannotti
Neuropsychiatric Disease and Treatment (2016), pp. 491-491
Open Access | Times Cited: 25

Showing 25 citing articles:

Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Structurally Enabled Discovery of Adenosine A2A Receptor Antagonists
Ali Jazayeri, Stephen P. Andrews, Fiona H. Marshall
Chemical Reviews (2016) Vol. 117, Iss. 1, pp. 21-37
Closed Access | Times Cited: 71
Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice
Fang Zhou, Xudong Yan, Chun Wang, et al.
Neurobiology of Aging (2020) Vol. 91, pp. 66-75
Closed Access | Times Cited: 50
Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
Russell Rosenberg, Leslie Citrome, Christopher L. Drake
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2549-2566
Open Access | Times Cited: 47
Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications
W. Joseph Herring, Thomas Roth, Andrew D. Krystal, et al.
Journal of Sleep Research (2018) Vol. 28, Iss. 2
Closed Access | Times Cited: 44
Impact of Sleep Disorder as a Risk Factor for Dementia in Men and Women
Hye Jin Jee, Wonseok Shin, Ho Joong Jung, et al.
Biomolecules & Therapeutics (2019) Vol. 28, Iss. 1, pp. 58-73
Open Access | Times Cited: 42
Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study
Yoshiki Ishibashi, Rie Nishitani, Akiyoshi Shimura, et al.
PLoS ONE (2020) Vol. 15, Iss. 9, pp. e0238723-e0238723
Open Access | Times Cited: 31
Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans
William W. Stoops, Justin C. Strickland, Kevin W. Hatton, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 220, pp. 173466-173466
Open Access | Times Cited: 15
Bioactive compounds from Ocimum tenuiflorum and Poria cocos: A novel natural Compound for insomnia treatment based on A computational approach
Onggan Ranteh, Aman Tedasen, Md. Atiar Rahman, et al.
Computers in Biology and Medicine (2024) Vol. 175, pp. 108491-108491
Closed Access | Times Cited: 2
Adverse reaction with suvorexant for insomnia: acute worsening of depression with emergence of suicidal thoughts
Jeremy Petrous, Kevin M. Furmaga
BMJ Case Reports (2017), pp. bcr-222037
Open Access | Times Cited: 23
Optogenetic activation of short neuropeptide F (sNPF) neurons induces sleep in Drosophila melanogaster
Zoe Juneau, Jamie M. Stonemetz, Ryan Toma, et al.
Physiology & Behavior (2019) Vol. 206, pp. 143-156
Open Access | Times Cited: 20
A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women
Shadab A. Rahman, Margo Nathan, Aleta Wiley, et al.
SLEEP (2022) Vol. 45, Iss. 3
Open Access | Times Cited: 12
Chronic Insomnia Disorder
Alon Y. Avidan, David N. Neubauer
CONTINUUM Lifelong Learning in Neurology (2017) Vol. 23, Iss. 4, pp. 1064-1092
Open Access | Times Cited: 20
Effectiveness of suvorexant versus benzodiazepine receptor agonist sleep drugs in reducing the risk of hip fracture: Findings from a regional population-based cohort study
Ryozo Yoshioka, Seiichiro Yamamoto, Eiji Nakatani
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284726-e0284726
Open Access | Times Cited: 5
Simple and Highly Sensitive UPLC-ESI-MS/MS Assay for Rapid Determination of Suvorexant in Plasma
Muzaffar Iqbal, Essam Ezzeldin, Nasr Y. Khalil, et al.
Journal of Analytical Toxicology (2016)
Open Access | Times Cited: 12
Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma‐aminobutyric acid–benzodiazepine receptor agonists or suvorexant
Kazumaro Okino, Hirohisa Suzuki, Hiroi Tomioka, et al.
Human Psychopharmacology Clinical and Experimental (2023) Vol. 38, Iss. 3
Closed Access | Times Cited: 4
The Orexin OX2 Receptor‐Dependent Pathway Is Implicated in the Development of Overactive Bladder and Depression in Rats Exposed to Corticosterone
Anna Serefko, Jan Wróbel, Aleksandra Szopa, et al.
Neurourology and Urodynamics (2024)
Open Access | Times Cited: 1
Effectiveness of change from suvorexant to lemborexant drug in the treatment of sleep disorders
Kazumaro Okino, Hirohisa Suzuki, Seiji Kondo, et al.
Psychogeriatrics (2022) Vol. 22, Iss. 5, pp. 595-604
Closed Access | Times Cited: 7
Suvorexant for insomnia in older adults: a perspective review
Rajesh R. Tampi, Geetha Manikkara, Silpa Balachandran, et al.
Drugs in Context (2018) Vol. 7, pp. 1-9
Open Access | Times Cited: 11
Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods
Jana Janočková, Rafael Doležal, Eugenie Nepovimová, et al.
Molecules (2018) Vol. 23, Iss. 11, pp. 2926-2926
Open Access | Times Cited: 8
Current Considerations in the Diagnosis and Treatment of Circadian Rhythm Sleep-Wake Disorders in Children
Rochelle M. Witt, Kelly C. Byars, Kristina M. Decker, et al.
Seminars in Pediatric Neurology (2023) Vol. 48, pp. 101091-101091
Open Access | Times Cited: 2
Insomnia: Will Medication Bring Rest?
Barbara J. Limandri
Journal of Psychosocial Nursing and Mental Health Services (2018) Vol. 56, Iss. 7, pp. 9-14
Closed Access | Times Cited: 5
Managing travel and jetlag in athletes
Ian C. Dunican, John A. Caldwell
Elsevier eBooks (2024), pp. 271-287
Closed Access
Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia).
Amnon A. Berger, Emily Sottosanti, Ariel Winnick, et al.
PubMed (2022) Vol. 52, Iss. 1, pp. 68-90
Closed Access | Times Cited: 2
Drugs affecting sleep and wakefulness: a review
Avishek Amar
International Journal of Basic & Clinical Pharmacology (2018) Vol. 7, Iss. 6, pp. 1057-1057
Open Access | Times Cited: 1
Page 1

Scroll to top